September 05, 2012
A consumer advocacy group sued the U.S. Food and Drug Administration Wednesday in Washington federal court, in a bid to force the agency to decide on its petition to pull a Pfizer Inc. Alzheimer's drug from the market over efficacy and safety concerns.